Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIFICO in Mild to Moderate Parkinson's Disease
NCT04871464Phase 4Unknown
- Sponsor
- Beijing Friendship Hospital
- Start
- Nov 2021
- Primary completion
- Oct 2023
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
A Phase 4 trial of bifidobacterium longum/lactobacillus acidophilus/enterococcus faecalis in Parkinson's disease (PD), sponsored by Beijing Friendship Hospital. Status: unknown.
02
Drugs
bifidobacterium longum/lactobacillus acidophilus/enterococcus faecalis
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04871464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04871464.